Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages
Authors: Léonard, S.; Pierard, I.; Michaelsen, T. E.1; Izui, S.2; Masson, P. L.3; Coutelier, J.-P.
Source: Clinical & Experimental Immunology, Volume 145, Number 1, July 2006 , pp. 155-161(7)
Publisher: Blackwell Publishing
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Abstract:
Summary Several autoimmune diseases, mainly autoantibody-mediated, are attenuated by infusion of total IgG (IVIg). The efficacy varies widely from one patient to another. Using an experimental model of in vitro phagocytosis of autoantibody-coated erythrocytes by mouse macrophages, we analysed the possible causes for such a variability. Our results indicated that the efficacy of the phagocytosis inhibition depends upon different factors, such as the isotype and the extent of polymerization of the immunoglobulin used for the treatment as well as the genetic background of the mice and the state of macrophage activation that can be influenced by concomitant viral infection. The development of an in vitro assay for the phagocytic activity of macrophages might improve the selection of patients susceptible to benefit from IVIg treatment.Keywords: autoantibodies; autoimmunity; macrophage; phagocytosis; total immunoglobulin
Document Type: Research article
DOI: 10.1111/j.1365-2249.2006.03117.x
Affiliations: 1: Division of Infectious Disease Control, Norwegian Institute of Public Health and School of Pharmacy, University of Oslo, Oslo, Norway, and 2: Department of Pathology and Immunology, Centre Médical Universitaire, Université de Genève, Switzerland 3: Unit of Experimental Medicine, Christian de Duve Institute of Cellular Pathology, Université Catholique de Louvain, Bruxelles, Belgium,
- Free Content
- New Content
- Subscribed Content
- Free Trial Content
Click here for Page Help